EF
VYGR icon

Empowered Funds’s Voyager Therapeutics VYGR Stock Holding History

Empowered Funds’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-48,200
Closed -$163K – 1864
2025
Q1 		$163K Buy
48,200
+994
+2% +$4.64K ﹤0.01% 1530
2024
Q4 		$268K Buy
47,206
+2,397
+5% +$15.5K ﹤0.01% 1410
2024
Q3 		$262K Buy
44,809
+2,278
+5% +$16.6K ﹤0.01% 1275
2024
Q2 		$336K Buy
42,531
+3,060
+8% +$25.7K 0.01% 1169
2024
Q1 		$367K Buy
39,471
+2,975
+8% +$25.1K 0.01% 1153
2023
Q4 		$308K Buy
+36,496
New +$265K 0.01% 1105

Other funds holding VYGR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Empowered Funds's VYGR Position: Q2 2025 in Review

Empowered Funds sold out of Voyager Therapeutics (VYGR) in Q2 2025, closing a stake of 48,200 shares — an estimated $163K sold.

Empowered Funds first reported a position in VYGR in Q4 2023 and held it in 6 quarters. The position peaked at $367K in Q1 2024. 112 funds tracked by Wall St. Rank hold VYGR as of Q2 2025.

  • Empowered Funds reported no remaining Voyager Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Empowered Funds sold 48,200 Voyager Therapeutics shares in Q2 2025, an estimated $163K.
  • Empowered Funds first reported a position in Voyager Therapeutics in Q4 2023 and held it in 6 quarters.
  • Empowered Funds's Voyager Therapeutics position peaked at $367K in Q1 2024.
  • 112 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2025.

Based on Empowered Funds's 13F filing for Q2 2025, filed 11 Aug 2025.